Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-04

FDA Approved: TACROLIMUS — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved a supplemental application from Amneal Pharmaceuticals NY LLC for tacrolimus and tacrolimus extended-release capsules, expanding the generic pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus (generic) (Tacrolimus)
  • Tacrolimus Extended-Release Capsules (generic) (Tacrolimus Extended-Release Capsules)

Snippet

SUPPL AP for TACROLIMUS (TACROLIMUS)